![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Dupixent positive phase 3 data in children one to 11 years of...
Press Release: Availability of the Q2 2024 Aide-mémoire Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on...
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs...
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and...
Communiqué de presse : Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique...
Sanofi: Information concerning the total number of voting rights and shares – May 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.59 | -1.7265718319 | 92.09 | 92.31 | 90.15 | 783 | 91.27460399 | DE |
4 | -0.79 | -0.865374082594 | 91.29 | 92.31 | 86.2 | 613 | 89.92006603 | DE |
12 | 3 | 3.42857142857 | 87.5 | 94.45 | 85.14 | 889 | 90.05394707 | DE |
26 | -1.5 | -1.63043478261 | 92 | 96.46 | 84.98 | 809 | 89.87661585 | DE |
52 | -7.84 | -7.97234085825 | 98.34 | 104.22 | 80.75 | 760 | 89.95447451 | DE |
156 | 2.66 | 3.02823315118 | 87.84 | 106.06 | 76.36 | 1078 | 89.85325537 | DE |
260 | 12.5 | 16.0256410256 | 78 | 106.06 | 68 | 1543 | 86.89657875 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions